{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"227","upperLimit":"451","value":"319"},{"groupId":"OG001","lowerLimit":"42","upperLimit":"121","value":"71"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"22"}],"units":"Participants"}],"title":"Age<24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"200","upperLimit":"463","value":"304"},{"groupId":"OG001","lowerLimit":"37","upperLimit":"163","value":"77"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"Age>=24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"244","upperLimit":"431","value":"324"},{"groupId":"OG001","lowerLimit":"53","upperLimit":"125","value":"81"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"32"}],"units":"Participants"}],"title":"Baseline HIV viral load <=75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"118","upperLimit":"528","value":"250"},{"groupId":"OG001","lowerLimit":"8","upperLimit":"257","value":"45"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Baseline HIV viral load >75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"178","upperLimit":"657","value":"341"},{"groupId":"OG001","lowerLimit":"44","upperLimit":"212","value":"97"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Baseline CD4 <=500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"229","upperLimit":"399","value":"302"},{"groupId":"OG001","lowerLimit":"39","upperLimit":"111","value":"66"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"title":"Baseline CD4 >500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"222","upperLimit":"584","value":"361"},{"groupId":"OG001","lowerLimit":"38","upperLimit":"155","value":"77"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"Nadir CD4 <=350"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"214","upperLimit":"421","value":"300"},{"groupId":"OG001","lowerLimit":"42","upperLimit":"134","value":"75"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"21"}],"units":"Participants"}],"title":"Nadir CD4>350"}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 6 at 7 and 24 months","dispersionType":"95% Confidence Interval","groups":[{"description":"Month 7 visit after enrollment","id":"OG000","title":"Month 7 Visit"},{"description":"Month 24 visit after enrollment","id":"OG001","title":"Month 24 Visit"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination and who were sero-negative for HPV 6 at baseline with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"at 7 and 24 Months","title":"Geometric Mean Titers for HPV 6 According to Participant Age, HIV Viral Load, CD4+ T Cell Count, and Nadir CD4 Level","type":"SECONDARY","unitOfMeasure":"mMU/mL"}